Search

everythinglearnresearchcommunity

for

Search:↓

Optical Coherence Tomography has potential in diagnosing hair loss and monitoring blood clotting, and could be improved for deeper tissue observation and better hair loss understanding.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Propranolol combined with injections caused skin changes in guinea pigs but didn't fully mimic psoriasis.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Topical eye β-blockers may cause hair loss.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.